Aguilo, Letecia .
HRN: 26-42-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2024
CEFUROXIME 1.5GM (VIAL)
12/28/2024
12/29/2024
IV
1.5g
Q8hrs
For OR
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes